CVE-2018-14787 Privilege escalation in IntelliSpace Cardiovascular (ISCV) products
An attacker with escalated privileges can execute arbitrary code with local administrative permissions by accessing writable executable folders in Philips ISCV products.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Local or same network only
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2018-14787?
CVE-2018-14787 is a high-severity vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products, published on 22 Aug 2018. It can only be exploited from the same machine or local network, with no action from the victim.
Official description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Weakness: CWE-269
Which versions are affected by CVE-2018-14787?
It affects 2 products.
Products include Philips Intellispace Cardiovascular, Philips Xcelera.
How do I fix CVE-2018-14787?
No fix has been published for CVE-2018-14787 yet. Limit exposure of the affected software until one is available.
Is CVE-2018-14787 being exploited?
There is no known exploitation of CVE-2018-14787 in the wild and no public exploit code.
Other vulnerabilities in Philips IntelliSpace Cardiovascular (ISCV) products
Sources
Also known as GHSA-29jf-w9mr-r2xp.